Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis

European Respiratory Journal

Volumn 49, Issue 4, 2017, Pages

  Frija Masson, Justine ^a,b   Martin, Clémence ^a,b   Regard, Lucile ^a,b   Lothe, Marie Noëlle ^a,b   Touqui, Lhousseine ^a   Durand, Aurélie ^a,c,d   Lucas, Bruno ^a,c,d   Damotte, Diane ^a,b   Alifano, Marco ^a,b   Fajac, Isabelle ^a,b   Burgel, Pierre Régis ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AP HP ^*  (France)

^c INSTITUT COCHIN   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL13 CHEMOKINE; INTERLEUKIN 17; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; CXCL13 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BRONCHIECTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOTHELIAL VENULE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOMETRY; MOUSE; NONHUMAN; PERIBRONCHIAL LYMPHOID NEOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE; TISSUE REGENERATION; VENULE; ANIMAL; C57BL MOUSE; COMPLICATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; LYMPHOID TISSUE; MICROBIOLOGY; PATHOLOGY;

ANIMALS; B-LYMPHOCYTES; BRONCHIECTASIS; CHEMOKINE CXCL12; CHEMOKINE CXCL13; CYSTIC FIBROSIS; FEMALE; HUMANS; INTERLEUKIN-17; LUNG; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES;

EID: 85034646044     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01873-2016     Document Type: Article

References (43)

1. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: Suppl. 1, i1–i58.
2. Stoltz DA, Meyerholz DK, Welsh MJ. Origins of cystic fibrosis lung disease. N Engl J Med 2015; 372: 351–362.
3. Tang AC, Turvey SE, Alves MP, et al. Current concepts: host–pathogen interactions in cystic fibrosis airways disease. Eur Respir Rev 2014; 23: 320–332.
4. Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J 2015; 45: 1446–1462.
5. Whitters D, Stockley R. Immunity and bacterial colonisation in bronchiectasis. Thorax 2012; 67: 1006–1013.
6. Silva JR, Jones JA, Cole PJ, et al. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989; 44: 668–673.
7. + T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998; 53: 685–691.
8. Regamey N, Tsartsali L, Hilliard TN, et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 2012; 67: 164–170.
9. Yadava K, Marsland BJ. Lymphoid follicles in chronic lung diseases. Thorax 2013; 68: 597–598.
10. Pitzalis C, Jones GW, Bombardieri M, et al. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 2014; 14: 447–462.
11. Randall TD. Bronchus-associated lymphoid tissue (BALT) structure and function. Adv Immunol 2010; 107: 187–241.
12. Pabst R, Gehrke I. Is the bronchus-associated lymphoid-tissue (BALT) an integral structure of the lung in normal mammals, including humans. Am J Respir Cell Mol Biol 1990; 3: 131–135.
13. Elliot JG, Jensen CM, Mutavdzic S, et al. Aggregations of lymphoid cells in the airways of nonsmokers, smokers, and subjects with asthma. Am J Respir Crit Care Med 2004; 169: 712–718.
14. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645–2653.
15. Germain C, Gnjatic S, Tamzalit F, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 2014; 189: 832–844.
16. Mansuet-Lupo A, Alifano M, Pécuchet N, et al. Intratumoral immune cell densities are associated with lung adenocarcinoma gene alterations. Am J Respir Crit Care Med 2016; 194: 1403–1412.
17. Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax 1952; 7: 213–239.
18. Hubeau C, Lorenzato M, Couetil JP, et al. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 2001; 124: 69–76.
19. Hwang JY, Randall TD, Silva-Sanchez A. Inducible bronchus-associated lymphoid tissue: taming inflammation in the lung. Front Immunol 2016; 7: 258.
20. Baay-Guzman GJ, Huerta-Yepez S, Vega MI, et al. Role of CXCL13 in asthma: novel therapeutic target. Chest 2012; 141: 886–894.
21. van der Strate BWA, Postma DS, Brandsma CA, et al. Cigarette smoke-induced emphysema: a role for the B cell? Am J Respir Crit Care Med 2006; 173: 751–758.
22. Moyron-Quiroz JE, Rangel-Moreno J, Kusser KR, et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004; 10: 927–934.
23. Huvenne W, Lanckacker EA, Krysko O, et al. Exacerbation of cigarette smoke-induced pulmonary inflammation by Staphylococcus aureus enterotoxin B in mice. Respir Res 2011; 12: 69.
24. Moghaddam SJ, Clement CG, De la Garza MM, et al. Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am J Respir Cell Mol Biol 2008; 38: 629–638.
25. Fleige H, Ravens S, Moschovakis GL, et al. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J Exp Med 2014; 211: 643–651.
26. Bracke KR, Verhamme FM, Seys LJ, et al. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188: 343–355.
27. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 2011; 12: 639–646.
28. Martin C, Thévenot G, Danel S, et al. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J 2011; 38: 939–946.
29. Burgel PR, Montani D, Danel C, et al. A morphometric study of mucins and small airway plugging in cystic fibrosis. Thorax 2007; 62: 153–161.
30. Rangel-Moreno J, Hartson L, Navarro C, et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006; 116: 3183–3194.
31. Hsia CC, Hyde DM, Ochs M, et al. An official research policy statement of the American Thoracic Society/ European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 2010; 181: 394–418.
32. Martin B, Auffray C, Delpoux A, et al. Highly self-reactive naive CD4 T cells are prone to differentiate into regulatory T cells. Nat Commun 2013; 4: 2209.
33. + T cells. Proc Natl Acad Sci USA 2013; 110: 13085–13090.
34. Brodlie M, McKean MC, Johnson GE, et al. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J 2011; 37: 1378–1385.
35. Worlitzsch D, Tarran R, Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002; 109: 317–325.
36. Toyoshima M, Chida K, Sato A. Antigen uptake and subsequent cell kinetics in bronchus-associated lymphoid tissue. Respirology 2000; 5: 141–145.
37. Polverino F, Cosio BG, Pons J, et al. B cell-activating factor. An orchestrator of lymphoid follicles in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192: 695–705.
38. Seys LJ, Verhamme FM, Schinwald A, et al. Role of B cell-activating factor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192: 706–718.
39. Goya S, Matsuoka H, Mori M, et al. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J Pathol 2003; 200: 82–87.
40. Hubeau C, Puchelle E, Gaillard D. Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis. J Allergy Clin Immunol 2001; 108: 524–529.
41. Ramsey KA, Ranganathan S, Park J, et al. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med 2014; 190: 1111–1116.
42. Livraghi-Butrico A, Kelly EJ, Klem ER, et al. Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation. Mucosal Immunol 2012; 5: 397–408.
43. Sethi S. Infection as a comorbidity of COPD. Eur Respir J 2010; 35: 1209–1215.